RxDoctor Payments Data

Seema Modi, MD

Geriatric Medicine · Plano, TXNPI 1043204423

Payments from drug & device makers

$937in general payments, 2019–2025

Across 44 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$152
  • AbbVie$140
  • Bayer$135
  • Boehringer Ingelheim$91
  • Novo Nordisk$75
  • GSK$60
  • plus $283 from 12 others

What the payments were for

  • Food & beverage$937100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$937 in reported general payments places this provider in the 75th percentile of 275 geriatric medicine providers in Texas.

See all geriatric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$45,548
Medicare patients
188
Services billed
794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$53,134
EliquisApixaban19$23,173
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,663
SymbicortBudesonide/Formoterol Fumarate20$8,257
Rosuvastatin Calcium153$3,176
Esomeprazole Magnesium18$2,447
Gabapentin107$2,371
Levothyroxine Sodium196$2,202
Albuterol Sulfate HfaAlbuterol Sulfate88$1,873
Azelastine Hcl42$1,581
Omeprazole60$1,499
Lidocaine18$1,349
Atorvastatin Calcium149$1,243
SynthroidLevothyroxine Sodium11$1,215
Diclofenac Sodium26$1,062

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$75$53,13438 claims
PfizerEliquis$44$23,17319 claims
GSKTrelegy Ellipta$60$15,66317 claims
AbbVieSynthroid$140$1,21511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 275 geriatric medicine providers in Texas.

Other geriatric medicine in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →